Baxter’s contract includes a maximum $40 million fixed-price award with economic-price-adjustment and indefinite-delivery/indefinite-quantity for its infusion pumps and accessories. The competitive acquisition had 105 offers received.
The five-year contract has no option periods with the location being Baxter’s Illinois base. The using customers are the Army, Navy, Air Force, Marine Corps and federal civilian agencies with a Nov. 11, 2025 ordering period end date, according to the DoD release.
A Baxter spokesperson told Drug Delivery Business that the award is for a common contracting vehicle used by the DoD and, while there is no formal purchase commitment, Baxter’s Spectrum IQ infusion pump will be accessible and can be purchased by healthcare facilities under the DoD and VA umbrellas through their electronic capital equipment electronic catalog.
“We are excited that our leading infusion platform will now be available to help care for our country’s military members, veterans and their families,” the spokesperson said via an emailed statement.